Navigation Links
CBI's 9th Annual Forum on Formulary and Reimbursement Strategies: Payer Perspectives
Date:8/16/2012

WOBURN, Mass., Aug. 16, 2012 /PRNewswire/ -- CBI recently added a new panelist, Lisa Delancy PharmD, JD, MBA formerly Director, Pharmacy Rebate Contracting and Network with WellCare Health Plans, to the 9th Annual Forum on Formulary and Reimbursement Strategies agenda.

This September 20-21, attendees will come together during the Payer Panel Discussion, What Payers Want - Dive Deep into the Payer Decision-Making Process, for an open dialogue discussion on payer expectations:

  • What is the impact of changes in Healthcare Policy on payer decision-making process?
  • How do health plans interact with employers on formulary decisions and drug utilization?
  • What are the preferred mediums of communication and deliverables to payers?

The complexities of the current healthcare landscape and the challenge of proving economic value in today's medicines dominates the responsibilities of senior-level bio/pharma executives involved in strategic reimbursement, managed markets, HEOR and pricing. With a strong agenda offering practical strategies, CBI's Forum on Formulary and Reimbursement Strategies offers valuable insights on current trends and proven methods of ensuring optimal formulary placement and improved market access in today's environment.

For more information, visit http://www.cbinet.com/formulary.

CBI, an Advanstar company, is the leading provider of market-driven, unbiased conferences for the pharmaceutical, biotechnology, medical device and healthcare industries. CBI offers specialized information presented in interactive formats by thought leaders and regulators.

Contact: Kristina Weljkovic
Phone number: 339-298-2285
Email address: Kristina.weljkovic@cbinet.com

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE CBI
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
2. Organogenesis Announces Annual College Scholarship Award Winner
3. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
4. New Annual US$3 Million Fundamental Physics Prize Recognizes Transformative Advances in the Field
5. China Cord Blood Corporation Files its Annual Report on Form 20-F
6. Hyland Software hosts annual user forum for ECM, EMR software
7. Life Science Professionals: Annual Career Fair Announced
8. Keryx Biopharmaceuticals to Present at The 7th Annual JMP Securities Healthcare Conference
9. Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
10. Sangamo BioSciences Announces Presentation at Seventh Annual JMP Securities Healthcare Conference
11. Genedata Screener to Present at 10th Annual Ion Channel Retreat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... ... April 20, 2017 , ... Parallel6™ , the leader in ... today that they were named one of the 2017 Top 10 eClinical Trial ... in the pharmaceutical industry. , “We take pride in honoring Parallel6 as one of ...
(Date:4/20/2017)... N.J. and PETACH TIKVAH, Israel ... BCLI), a leading developer of adult stem cell technologies for ... Executive Officer, will present at the Alliance for Regenerative Medicine,s ... Day on Thursday, April 27, 2017 at 09:40 EDT in ... Ralph Kern , MD, MHSc, Chief Medical Officer & ...
(Date:4/19/2017)... ... ... A number of new instruments have recently emerged to accommodate different applications ... and Cell Analysis Education Webinar Series , will focus on advances in the Invitrogen™ ... applications. , Many flow cytometers have unique capabilities and the Attune NxT Flow ...
(Date:4/19/2017)... ... April 19, 2017 , ... Nobilis Therapeutics Announces Completion ... to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial , ... patient clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in the treatment ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
Breaking Biology News(10 mins):